date:Feb 11, 2019
mation. The FDA is committed to sharing new approaches considered through this program with the broader drug supply chain community on the agencys website. Our goal is to ensure that all parties can be apprised of its progress and take advantage of any shared learning.
The FDA has previously taken steps to advance the development and adoption of technologies that can help identify and properly trace prescription drugs as they move through the supply chain. For example, the FDA recently issued d